The SAFER program is helping Ukrainian children with cancers and other blood disorders to continue their therapy in Ukraine at centers in Europe and North America.

This review describes specialized programs for adolescent and young adults with cancer and the process undertaken by a US facility to develop its program.

Each 10% increase in PSA screening rates was significantly associated with a 9% decrease in the metastatic prostate cancer rates, according to a study of VA medical centers.

An overview of a proposed expansion to the CMS Merit-Based Incentive Payment System Value Pathways that supports specialty-specific quality of care measures for oncology.

Researchers investigated the benefits and drawbacks of pet ownership while coping with cancer and managing treatment.

Final results from the TITAN-RCC trial demonstrate improvements in objective response rates compared with nivolumab monotherapy.

Experts discuss the challenges and potential resolutions for increasing diversity of clinical trial study populations.

PSMA expression on circulating tumor cells in men with mCRPC increases upon disease progression despite treatment with novel antiandrogens.

Surrogate decision makers for a patient are obligated to make health care decisions based on what the patient would have wanted if it is known.

This review of polypharmacy in older patients with cancer highlights the adverse effects these patients may experience due to multiple simultaneous prescriptions.